102.78
price up icon0.22%   0.225
after-market 시간 외 거래: 99.96 -2.82 -2.74%
loading
전일 마감가:
$102.56
열려 있는:
$103.34
하루 거래량:
1.54M
Relative Volume:
0.42
시가총액:
$18.72B
수익:
$381.03M
순이익/손실:
$-1.01B
주가수익비율:
-17.27
EPS:
-5.95
순현금흐름:
$-789.25M
1주 성능:
+0.87%
1개월 성능:
+0.10%
6개월 성능:
+33.92%
1년 성능:
+35.29%
1일 변동 폭
Value
$101.77
$103.50
1주일 범위
Value
$100.85
$105.35
52주 변동 폭
Value
$60.40
$106.83

Insmed Inc Stock (INSM) Company Profile

Name
명칭
Insmed Inc
Name
전화
908-977-9900
Name
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
직원
1,271
Name
트위터
@insmed
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
INSM's Discussions on Twitter

INSM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
INSM
Insmed Inc
102.78 19.35B 381.03M -1.01B -789.25M -5.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Insmed Inc Stock (INSM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-13 개시 Jefferies Buy
2025-02-25 개시 RBC Capital Mkts Outperform
2024-04-23 개시 Truist Buy
2024-02-15 개시 Wolfe Research Outperform
2023-12-08 개시 Wells Fargo Overweight
2023-11-20 재개 JP Morgan Overweight
2023-07-26 개시 Guggenheim Buy
2022-12-09 개시 Mizuho Buy
2022-12-07 개시 Barclays Overweight
2022-11-18 개시 BofA Securities Buy
2022-04-27 개시 Goldman Buy
2021-12-06 개시 JP Morgan Overweight
2021-10-19 재개 Monness Crespi & Hardt Buy
2021-10-19 재개 Morgan Stanley Overweight
2021-10-08 개시 Cantor Fitzgerald Overweight
2021-04-26 재개 Credit Suisse Outperform
2020-12-17 개시 Berenberg Buy
2020-10-12 재개 Stifel Buy
2019-09-03 개시 Goldman Buy
2019-04-09 재확인 H.C. Wainwright Buy
2019-02-15 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 업그레이드 Goldman Neutral → Buy
2019-01-02 개시 Canaccord Genuity Buy
2018-08-06 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 개시 Goldman Neutral
2018-04-23 업그레이드 Credit Suisse Neutral → Outperform
2018-03-21 개시 Morgan Stanley Overweight
2018-01-18 개시 Credit Suisse Neutral
2017-09-05 재확인 Evercore ISI Outperform
2017-08-17 개시 Evercore ISI Outperform
2017-07-11 개시 Robert W. Baird Outperform
2016-03-15 개시 Stifel Buy
2015-11-09 다운그레이드 UBS Buy → Neutral
2015-10-06 재확인 H.C. Wainwright Buy
2015-06-09 개시 Citigroup Neutral
2014-03-26 재확인 HC Wainwright Buy
모두보기

Insmed Inc 주식(INSM)의 최신 뉴스

pulisher
11:38 AM

What drives Insmed Incorporated stock pricePowerful market insights - Autocar Professional

11:38 AM
pulisher
Jul 20, 2025

What analysts say about Insmed Incorporated stockMarket-beating performance - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Is Insmed Incorporated a good long term investmentOver 200% growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 17, 2025

Insmed's Trading Volume Drops 46% to $208 Million Ranking 490th in Market - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Insmed (INSM) Target Price Raised by Morgan Stanley | INSM Stock News - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

Insmed price target raised to $108 from $102 at Morgan Stanley - TipRanks

Jul 17, 2025
pulisher
Jul 16, 2025

Insmed (INSM) Price Target Raised to $108 by Morgan Stanley | IN - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Insmed Incorporated stock price move sharplyFree Capital Allocation Plans - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Insmed chief legal officer Smith sells $167,755 in stock By Investing.com - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

Insmed chair and CEO Lewis sells $699k in shares By Investing.com - Investing.com Canada

Jul 15, 2025
pulisher
Jul 14, 2025

Jim Cramer Calls Insmed "Very Speculative" - Yahoo Finance

Jul 14, 2025
pulisher
Jul 11, 2025

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Benzinga

Jul 11, 2025
pulisher
Jul 11, 2025

Insmed Surges to 292nd in Trading Volume with $31.9 Million Turnover - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Cramer Says Tesla Dominates While Ouster Is 'Too Speculative' - Benzinga

Jul 10, 2025
pulisher
Jul 09, 2025

Insmed(INSM.US) Officer Sells US$5.54 Million in Common Stock - 富途牛牛

Jul 09, 2025
pulisher
Jul 08, 2025

JPMorgan Elevates Insmed (INSM) Target Price Amid Positive Outlo - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

A Glimpse Into The Expert Outlook On Insmed Through 12 Analysts - Nasdaq

Jul 08, 2025
pulisher
Jul 08, 2025

RBC Capital Keeps Their Buy Rating on Insmed (INSM) - The Globe and Mail

Jul 08, 2025
pulisher
Jul 01, 2025

United Therapeutics Faces Key Moment With Tyvaso's Q3 Results - Finimize

Jul 01, 2025
pulisher
Jun 30, 2025

Insmed Incorporated(NasdaqGS: INSM) added to Russell Small Cap Comp Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Insmed Incorporated: Riding the Russell Reconstitution Wave in Small-Cap Biotech - AInvest

Jun 29, 2025
pulisher
Jun 27, 2025

Insmed Surges to 134th in Trading Volume with $612 Million Day Despite Stock Decline - AInvest

Jun 27, 2025
pulisher
Jun 26, 2025

Here’s how Insmed grows to be the next $100 billion biotech - statnews.com

Jun 26, 2025
pulisher
Jun 25, 2025

Insmed's Insider Sell-Off: Strategic Exit or Buying Opportunity Ahead of Breakthrough Data? - AInvest

Jun 25, 2025
pulisher
Jun 23, 2025

Pulmonary Arterial Hypertension Market Set to Grow Substantially Through 2034, DelveInsight Projects | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma, Keros - Barchart.com

Jun 23, 2025
pulisher
Jun 20, 2025

Russell Rebalance: 3 Stocks Ready to Move Higher - MarketBeat

Jun 20, 2025
pulisher
Jun 18, 2025

Insider Sell: Roger Adsett Sells 10,686 Shares of Insmed Inc (INSM) - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110 - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

10 Best Growth Stocks to Buy According to Billionaires - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Is Insmed Stock Overvalued at $98? - Nasdaq

Jun 17, 2025
pulisher
Jun 16, 2025

Insmed Completes $750 Million Follow-On Public Offering - Global Legal Chronicle

Jun 16, 2025
pulisher
Jun 16, 2025

Is Insmed Stock Overvalued After The 45% Jump? - Forbes

Jun 16, 2025
pulisher
Jun 15, 2025

Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio? - Benzinga

Jun 15, 2025
pulisher
Jun 15, 2025

Insmed Inc (INSM) Soars 30% on Impressive Study - MSN

Jun 15, 2025
pulisher
Jun 13, 2025

Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results - Insider Monkey

Jun 13, 2025
pulisher
Jun 13, 2025

INSM September 19th Options Begin Trading - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

Insmed (INSM) Soars After Raising $650 million - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Stock Jumps 29% on Encouraging PAH Study Results - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Finance Watch: Insmed Cashes In On Positive Data With $750m Offering - insights.citeline.com

Jun 12, 2025
pulisher
Jun 12, 2025

SEC Form 424B5 filed by Insmed Incorporated - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed prices capital raise of $750 via stock offering - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed announces $650M public offering of common stock - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Stock Ends Volatile Session Lower, Pauses After Monumental 32% Weekly Surge - Daily Chhattisgarh News

Jun 12, 2025

Insmed Inc (INSM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Insmed Inc 주식 (INSM) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Lewis William
Chair and CEO
Jul 15 '25
Sale
102.37
6,830
699,220
233,924
Smith Michael Alexander
Chief Legal Officer
Jul 15 '25
Sale
102.51
933
95,642
66,394
Smith Michael Alexander
Chief Legal Officer
Jul 11 '25
Sale
96.41
748
72,115
67,327
$26.34
price up icon 0.53%
$35.65
price up icon 0.17%
$21.69
price down icon 0.87%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):